• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

tetano

Editor, Senior Moderator
Cell Rep


. 2021 Jun 8;109305.
doi: 10.1016/j.celrep.2021.109305. Online ahead of print.
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics


Adi Nagler[SUP] 1 [/SUP], Shelly Kalaora[SUP] 1 [/SUP], Chaya Barbolin[SUP] 1 [/SUP], Anastasia Gangaev[SUP] 2 [/SUP], Steven L C Ketelaars[SUP] 2 [/SUP], Michal Alon[SUP] 1 [/SUP], Joy Pai[SUP] 3 [/SUP], Gil Benedek[SUP] 4 [/SUP], Yfat Yahalom-Ronen[SUP] 5 [/SUP], Noam Erez[SUP] 5 [/SUP], Polina Greenberg[SUP] 1 [/SUP], Gal Yagel[SUP] 1 [/SUP], Aviyah Peri[SUP] 1 [/SUP], Yishai Levin[SUP] 6 [/SUP], Ansuman T Satpathy[SUP] 3 [/SUP], Erez Bar-Haim[SUP] 7 [/SUP], Nir Paran[SUP] 5 [/SUP], Pia Kvistborg[SUP] 4 [/SUP], Yardena Samuels[SUP] 8 [/SUP]



Affiliations

Abstract

The human leukocyte antigen (HLA)-bound viral antigens serve as an immunological signature that can be selectively recognized by T cells. As viruses evolve by acquiring mutations, it is essential to identify a range of presented viral antigens. Using HLA peptidomics, we are able to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-derived peptides presented by highly prevalent HLA class I (HLA-I) molecules by using infected cells as well as overexpression of SARS-CoV-2 genes. We find 26 HLA-I peptides and 36 HLA class II (HLA-II) peptides. Among the identified peptides, some are shared between different cells and some are derived from out-of-frame open reading frames (ORFs). Seven of these peptides were previously shown to be immunogenic, and we identify two additional immunoreactive peptides by using HLA multimer staining. These results may aid the development of the next generation of SARS-CoV-2 vaccines based on presented viral-specific antigens that span several of the viral genes.

Keywords: HLA; Peptides; Peptidomics; SARS-CoV-2; immuno-reactive; out-of-frame-ORFs.
 
Back
Top Bottom